Lipitaezar targets fat accumulation and inflammation, addressing the root cause of NAFLD (Non-Alcoholic Fatty Liver Disease) while supporting metabolic balance. It helps reduce liver stress and promotes overall health.
Lipitaezar enhances bile production, aiding in efficient fat breakdown and digestion. This supports smoother metabolism and reduces strain on the liver.
With potent hepatoprotective properties, Lipitaezar helps revitalize and repair liver cells. Its antioxidant-rich formula shields the liver from damage, promoting long-term liver health.
Helps eliminate harmful toxins and supports natural liver cleansing for improved liver function and overall well-being.
Enhances bile production to support better digestion and nutrient absorption.
Rejuvenates damaged liver cells, promoting better liver function and overall health.
Enhances fat metabolism, reducing strain on the liver and supporting overall metabolic health.
Daruharidra Rhizome/Bark Extract std. to Berberine NLT 2%
Katuki Root Extract std. to Picroside 5%
Rohitaka Bark Extract std. to Tannins NLT 10%
Kalmegh Plant Extract std. to Andrographolides NLT 10%
Arjun Bark Extract std. to Arjunolic acid 0.8% Tannins 20%
Amalaki Fruit Extract std. to Tannins NLT 15%
Haritaki Fruit Extract std. to Tannins NLT 10%
Bibhitaki Fruit Extract std. to Tannins NLT 10%
Kasni Seed Extract std. to Bitter 1%
Regulates lipid metabolism, Inhibits hepatic lipogenesis, Improves insulin resistance, Glucose metabolism, improves liver function.
Reduces hepatic lipid content, Hypolipidemic, and reduces cholestatis, Potent choleretic, Hepatoprotective
Hepatoprotective, Antioxidant, Anti-inflammatory, Improves bile flow
Hepatoprotective, Hypolipidemic, Antioxidant, Anti-inflammatory, Improves bile flow
Hepatoprotective, Hypolipidemic, Antioxidant
Hepatoprotective, Hypolipidemic, Antioxidant, Hypocholesteremic.
Hepatoprotective, Hypolipidemic, Antioxidant
Hepatoprotective, Antioxidant
Hepatoprotective, Hypolipidemic, Antidiabetic, Antioxidant.
Non-alcoholic fatty liver disease or NAFLD is when fat is increased in the liver and there is not a clear cause such as excessive alcohol use. The fat deposits can cause liver damage.
NAFLD is divided into two types: simple fatty liver and nonalcoholic steatohepatitis (NASH). Most people with NAFLD have simple fatty liver, however 25-30% have NASH. With NASH, there is inflammation and scarring of the liver. A small number of people will develop significant scarring in their liver, called cirrhosis.
People with NAFLD often have one or more features of metabolic syndrome: obesity, high blood pressure, low HDL cholesterol, insulin resistance or diabetes.
NAFLD is now a leading cause of chronic liver disease worldwide. The worldwide prevalence of NAFLD is about 25%, ranging from 13% in Africa to 23% in Europe and 32% in the Middle East.
There is a close association with type 2 diabetes, central obesity, dyslipidaemia and the metabolic syndrome.. Consequently, the burden of disease has increased from 15% in 2005 to 25% in 2010 in parallel to rising rates of obesity.
The most common cause of death in patients with NAFLD is cardiovascular disease (40%).
Lipitaezar offers multiple liver health benefits, including:
Lipitaezar is suitable for:
Results may vary based on individual health conditions and lifestyle. However, most users may experience:
1 tablet twice daily.
Getting started with Lipitaezar is simple:
